Physician profile
Kelly E Wingerter
NPI 1073957072
$1,538.93
in general payments reported to CMS, 2019-2025
12 companies · $1,001 in 2025
The $1,001 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $105 · 2021: $140 · 2025: $1,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $749 · Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $749.47 |
| Food and Beverage | $251.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,082.63 | 2019-2025 | Triclip |
| Pfizer INC. | $135.89 | 2020-2021 | |
| Astellas Pharma US INC | $99.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.59 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $22.98 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $20.80 | 2021 | |
| Novo Nordisk INC | $19.25 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $18.54 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $17.33 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.89 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.32 | 2020 | |
| Irhythm Technologies, INC. | $13.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Wingerter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.